Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: DEXORGEN INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-09 to 2023-03-31
Current total value of award: $14700
Description: CONSTRUCT 293T STABLE CELL LINES THAT STABLY EXPRESS SARS2 SPIKE BA.4 AND BA.5 VARIANTS AND MCHERRY FLUORESCENCE PROTEIN (COVID-19)